Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Ban

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Lipid Research|December 4, 2004
Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemiaJian Wang, Matthew R Ban, Robert A Hegele
The Canadian Journal of Cardiology|December 3, 2014
The effect of infrequent low-dose rosuvastatin on the lipid profileChristine Ibrahim, Matthew R Ban, Robert A Hegele
The Canadian Journal of Cardiology|July 31, 2012
Clinical equivalence of proprietary and generic atorvastatin in lipid clinic patientsAmit R Rahalkar, Matthew R Ban, Robert A Hegele
Stroke|April 12, 2003
Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaqueJ David Spence, Matthew R Ban, Robert A Hegele
Lipids in Health and Disease|August 16, 2005
NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibeRobert A Hegele, Justin Guy, Matthew R Ban, et al.
CJC Open|March 12, 2020
Efficacy of Evolocumab in Monogenic vs Polygenic HypercholesterolemiaTimothy Lee, Michael A Iacocca, Matthew R Ban, et al.
Lipids in Health and Disease|March 23, 2007
Genetic determinants of statin intoleranceJisun Oh, Matthew R Ban, Brooke A Miskie, et al.
The Canadian Journal of Cardiology|March 8, 2013
Efficacy and plasma drug concentrations with nondaily dosing of rosuvastatinAlyse S Goldberg, Marianne K DeGorter, Matthew R Ban, et al.
Journal of Lipid Research|February 3, 2009
Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-IChandheeb Rajakumar, Matthew R Ban, Henian Cao, et al.
CJC Open|March 12, 2020
Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk ScoreRobin Liu, Jiahui Cheng, Carlos Muzlera, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Lipid Research|December 4, 2004
Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemiaJian Wang, Matthew R Ban, Robert A Hegele
The Canadian Journal of Cardiology|December 3, 2014
The effect of infrequent low-dose rosuvastatin on the lipid profileChristine Ibrahim, Matthew R Ban, Robert A Hegele
The Canadian Journal of Cardiology|July 31, 2012
Clinical equivalence of proprietary and generic atorvastatin in lipid clinic patientsAmit R Rahalkar, Matthew R Ban, Robert A Hegele
Stroke|April 12, 2003
Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaqueJ David Spence, Matthew R Ban, Robert A Hegele
Lipids in Health and Disease|August 16, 2005
NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibeRobert A Hegele, Justin Guy, Matthew R Ban, et al.
CJC Open|March 12, 2020
Efficacy of Evolocumab in Monogenic vs Polygenic HypercholesterolemiaTimothy Lee, Michael A Iacocca, Matthew R Ban, et al.
Lipids in Health and Disease|March 23, 2007
Genetic determinants of statin intoleranceJisun Oh, Matthew R Ban, Brooke A Miskie, et al.
The Canadian Journal of Cardiology|March 8, 2013
Efficacy and plasma drug concentrations with nondaily dosing of rosuvastatinAlyse S Goldberg, Marianne K DeGorter, Matthew R Ban, et al.
Journal of Lipid Research|February 3, 2009
Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-IChandheeb Rajakumar, Matthew R Ban, Henian Cao, et al.
CJC Open|March 12, 2020
Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk ScoreRobin Liu, Jiahui Cheng, Carlos Muzlera, et al.
Pageof 4